关注
Hugo Albrecht
Hugo Albrecht
在 unisa.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors
U Hengst, H Albrecht, D Hess, D Monard
Journal of Biological Chemistry 276 (1), 535-540, 2001
2242001
Bcl‐2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF‐κB by TNF
H Albrecht, J Tschopp, CV Jongeneel
FEBS letters 351 (1), 45-48, 1994
1231994
Cercarial elastase is encoded by a functionally conserved gene family across multiple species of schistosomes
JP Salter, Y Choe, H Albrecht, C Franklin, KC Lim, CS Craik, ...
Journal of Biological Chemistry 277 (27), 24618-24624, 2002
1212002
CDK9: a comprehensive review of its biology, and its role as a potential target for anti-cancer agents
AT Anshabo, R Milne, S Wang, H Albrecht
Frontiers in oncology 11, 678559, 2021
872021
Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3H)‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation
S Diab, T Teo, M Kumarasiri, P Li, M Yu, F Lam, SKC Basnet, MJ Sykes, ...
ChemMedChem 9 (5), 962-972, 2014
822014
Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor γ activity: a combined virtual screening and biological assay approach
M Scarsi, M Podvinec, A Roth, H Hug, S Kersten, H Albrecht, T Schwede, ...
Molecular pharmacology 71 (2), 398-406, 2007
792007
Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug …
S Tadesse, M Yu, LB Mekonnen, F Lam, S Islam, K Tomusange, ...
Journal of Medicinal Chemistry 60 (5), 1892-1915, 2017
692017
Targeting CDK9: a promising therapeutic opportunity in prostate cancer
MH Rahaman, M Kumarasiri, LB Mekonnen, M Yu, S Diab, H Albrecht, ...
Endocrine-related cancer 23 (12), T211-T226, 2016
692016
Regulation of brain proteolytic activity is necessary for the in vivo function of NMDA receptors
M Kvajo, H Albrecht, M Meins, U Hengst, E Troncoso, S Lefort, JZ Kiss, ...
Journal of Neuroscience 24 (43), 9734-9743, 2004
592004
Use of FLIPR membrane potential dyes for validation of high-throughput screening with the FLIPR and µARCS technologies: identification of ion channel modulators acting on the …
C Joesch, E Guevarra, SP Parel, A Bergner, P Zbinden, D Konrad, ...
Journal of biomolecular screening 13 (3), 218-228, 2008
512008
trans activation of the tumor necrosis factor alpha promoter by the human T-cell leukemia virus type I Tax1 protein
H Albrecht, AN Shakhov, CV Jongeneel
Journal of virology 66 (10), 6191-6193, 1992
481992
Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles
W Zhang, Y Song, P Eldi, X Guo, JD Hayball, S Garg, H Albrecht
International Journal of Nanomedicine, 293-305, 2018
442018
CDK5 in oncology: recent advances and future prospects
JL Lenjisa, S Tadesse, NZ Khair, M Kumarasiri, M Yu, H Albrecht, R Milne, ...
Future medicinal chemistry 9 (16), 1939-1962, 2017
422017
Pharmacologic inhibition of MNKs in acute myeloid leukemia
T Teo, F Lam, M Yu, Y Yang, SKC Basnet, H Albrecht, MJ Sykes, S Wang
Molecular pharmacology 88 (2), 380-389, 2015
412015
Discovery of 4-(dihydropyridinon-3-yl) amino-5-methylthieno [2, 3-d] pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and …
M Yu, P Li, SKC Basnet, M Kumarasiri, S Diab, T Teo, H Albrecht, S Wang
European journal of medicinal chemistry 95, 116-126, 2015
412015
Nuclear migration of NF-kappa B correlates with TNF-alpha mRNA accumulation.
H Albrecht, LB Schook, CV Jongeneel
Journal of inflammation 45 (1), 64-71, 1995
401995
Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: Potential for active targeting with engineered anti-cancer nanomedicines
E Kübler, H Albrecht
Oncotarget 9 (38), 24882, 2018
352018
Single amino acid substitutions in the B870 α and β light‐harvesting polypeptides of Rhodobacter capsulatus Structural and spectral effects
M Babst, H Albrecht, I Wegmann, R Brunisholz, H Zuber
European journal of biochemistry 202 (2), 277-284, 1991
351991
An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis
T Teo, Y Yang, M Yu, SKC Basnet, T Gillam, J Hou, RM Schmid, ...
European journal of medicinal chemistry 103, 539-550, 2015
342015
Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia
S Diab, AM Abdelaziz, P Li, T Teo, SKC Basnet, B Noll, MH Rahaman, ...
European Journal of Medicinal Chemistry 139, 762-772, 2017
312017
系统目前无法执行此操作,请稍后再试。
文章 1–20